S'abonner

In Situ Transesophageal Echocardiography During Electrical Cardioversion in Patients With Atrial Fibrillation—Safety and Echocardiographic Findings - 02/04/24

Doi : 10.1016/j.echo.2023.11.022 
Mehrnoush Toufan Tabrizi, MD a, Marlene Girardo, MS b, Tasneem Z. Naqvi, MD, MMM a,
a Division of Echocardiography, Department of Medicine, Mayo Clinic, Scottsdale, Arizona 
b Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona 

Reprint requests: Tasneem Z. Naqvi, MD, MMM, 5777 East Mayo Boulevard, Phoenix, AZ 85054.5777 East Mayo BoulevardPhoenixAZ85054

Abstract

Background

Transesophageal echocardiography (TEE) can reliably detect left atrial (LA) and LA appendage (LAA) thrombus in patients with atrial fibrillation (AF) before electrical cardioversion (ECV). However, evaluating cardiac and valve function pre-ECV can be challenging due to the increased and irregular heart rate. Additionally, post-ECV atrial stunning increases the risk of LAA thrombosis. Therefore, post-ECV TEE may allow for useful appendage, ventricular, and valve function assessment. However, the safety and usefulness of leaving the TEE probe in situ during ECV for post-ECV cardiac evaluation in clinical practice have not been previously evaluated.

Methods

We analyzed 37 out of 86 consecutive patients who had the TEE probe left in situ, for clinical reasons, during ECV by a single operator between February 20, 2019, and January 3, 2023. We examined changes in left ventricular (LV) function, dynamic changes in valvular regurgitation, electromechanical coupling of the left atrium, and qualitative spontaneous echo contrast. We also assessed the presence of any complications related to the periprocedural TEE exam.

Results

The mean age of the patients was 74 ± 9.65 years, and 29 (78%) were male. The periprocedural TEE time ranged from 7 to 55 minutes, with an average of 20.78 minutes. Immediately after ECV and restoration of normal sinus rhythm, there was an improvement in LV ejection fraction (47% ± 11.9% vs 40% ± 15.8%; P = .035). There was also a reduction in baseline mitral regurgitation of greater than moderate degree. However, spontaneous echo contrast worsened in the LAA in 11 (31.4%) patients. Additionally, 1 patient developed a new LAA thrombus, and 24 patients (72%) had evidence of electromechanical coupling with Doppler evidence of LA contraction. Clinically significant degenerative aortic and mitral stenosis were identified in 8% and mild or greater aortic regurgitation in 8% of patients post-ECV. No procedural complications were observed.

Conclusions

In situ TEE before, during, and after ECV is safe and provides useful clinical information regarding immediate cardiac changes after ECV, with diagnostic and therapeutic implications.

Le texte complet de cet article est disponible en PDF.

Highlights

ECV during TEE probe in situ was safe in 37 patients.
Post-ECV TEE showed improvement in LVEF and reduction in moderate MR.
LAA spontaneous contrast worsened in one-third of patients.
A new LAA thrombus developed in 1 patient on anticoagulation.
More than moderate AS, mitral stenosis, and aortic regurgitation were found in 16% of patients.

Le texte complet de cet article est disponible en PDF.

Keywords : Transesophageal echocardiography, Electrical cardioversion, Atrial fibrillation, LVEF, Spontaneous echo contrast

Abbreviations : 2D, 3D, AF, AFL, AS, CW, DOAC, ECV, EM, LA, LV, LVEF, MR, NSR, PW, RA, RV, SEC, TEE, TR, TTE


Plan


 Allan L. Klein, MD, served as guest editor for this report.


© 2023  American Society of Echocardiography. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 37 - N° 4

P. 420-427 - avril 2024 Retour au numéro
Article précédent Article précédent
  • Clinical Impact of the Volumetric Quantification of Ventricular Secondary Mitral Regurgitation by Three-Dimensional Echocardiography
  • Michele Tomaselli, Luigi P. Badano, Giorgio Oliverio, Emanuele Curti, Cinzia Pece, Paolo Springhetti, Salvatore Milazzo, Alexandra Clement, Marco Penso, Mara Gavazzoni, Diana R. Hădăreanu, Sorina Baldea Mihaila, Giordano M. Pugliesi, Caterina Delcea, Denisa Muraru
| Article suivant Article suivant
  • Combined Assessment of Fractional Flow Reserve and Coronary Flow Velocity Reserve after Drug-Eluting Stent Implantation
  • Yoshihiro Hanyu, Masahiro Hoshino, Eisuke Usui, Tomoyo Sugiyama, Yoshihisa Kanaji, Masahiro Hada, Tatsuhiro Nagamine, Kai Nogami, Hiroki Ueno, Tatsuya Sakamoto, Taishi Yonetsu, Tetsuo Sasano, Tsunekazu Kakuta

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.